US3716639A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Anorexigenic tetrahydrobenzazepines
Assignee: Novartis Corp
•
Filing: 1970-03-11
•
Granted: 1973-02-13
•
Expires: 1990-03-11
Abstract
Abstract 7-CHLORO-2,3,4,5-TETRAHYDRO-1H-3-benzazepines and pharmaceutically acceptable acid addition salts thereof are prepared; therapeutical compositions containing said compounds and methods for producing an anorexigenic effect in a mammal are provided.
Inventors
- 👤 K Hoegerle
- 👤 E Habicht
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 23:48
CPC Classifications
C; C07; C07D; C07D203/00; C07D203/04; C07D203/06; C07D203/08; C07D223/00; C07D223/14; C07D223/16
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
42 words
A method of producing an anorexigenic effect in a mammal suffering from obesity comprising administering to that mammal an anorexigenically effective amount of a compound of the formula wherein R is hydrogen or methyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim
42 words
A method of producing an anorexigenic effect in a mammal suffering from obesity comprising administering to that mammal an anorexigenically effective amount of a compound of the formula wherein R is hydrogen or methyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
11 words
A method according to claim 1 wherein said compound is 7-chloro-2,3,4,5-tetrahydro-1H-3-benzazepine.
Claim 4
Dependent Claim
11 words
A method according to claim 1 wherein said compound is 2-methyl-7-chloro-2,3,4,5-tetrahydro-1H-3-benzazepine.
Claim 5
Dependent Claim
36 words
A therapeutic composition consisting essentially of an anorexigenically effective amount of a compound of the formula wherein R is hydrogen or methyl or a pharmaceutically acceptable acid addition salt thereof and a solid pulverulent pharmaceutical carrier.
Claim 6
Dependent Claim
36 words
A therapeutic composition consisting essentially of an anorexigenically effective amount of a compound of the formula wherein R is hydrogen or methyl or a pharmaceutically acceptable acid addition salt thereof and a solid pulverulent pharmaceutical carrier.
Claim 7
Dependent Claim
12 words
A therapeutic composition according to claim 4 wherein said compound is 7-chloro-2,3,4,5-tetrahydro-1H-3-benzazepine.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1976-02-13 | 1976-08-14 | 1977-02-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1980-02-13 | 1980-08-14 | 1981-02-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1984-02-13 | 1984-08-14 | 1985-02-13 | $7700.00 | Window Closed / Lapsed |